News for 'Emergency Use Authorisation'

Bareilly violence: 8 properties linked to Dargah cleric to be razed

Bareilly violence: 8 properties linked to Dargah cleric to be razed

Rediff.com1 Oct 2025

Authorities in Bareilly have identified and are taking action against allegedly illegal properties linked to associates of Ittehad-e-Millat Council (IMC) chief cleric Tauqeer Raza Khan following violent clashes in the city.

Officials hint at 'political interests' behind Manipur ambush

Officials hint at 'political interests' behind Manipur ambush

Rediff.com5 Oct 2025

Security forces in Manipur have launched a major crackdown on the banned People's Liberation Army (PLA) following an ambush on an Assam Rifles convoy. Fifteen cadres have been arrested, including suspects directly involved in the attack. Investigations are underway to determine if the PLA has political patronage and if weapons looted during ethnic clashes are being used against security forces.

Revealed! What Led To The 1962 War?

Revealed! What Led To The 1962 War?

Rediff.com20 Oct 2025

As India and China continue to face off across the Himalayas six decades later, the echoes of that earlier conflict remain unmistakable. The core of China's sensitivity lies not in maps or mountain passes, but in its perception of sovereignty over Tibet, points out Dr Kumar.

DCGI approves market authorisation for Covovax as Covid booster dose

DCGI approves market authorisation for Covovax as Covid booster dose

Rediff.com17 Jan 2023

The DCGI's approval came following recommendation by the Subject Expert Committee of the Central Drugs Standard Control Organisation.

EPS Shows BJP Who Is The Boss in Tamil Nadu

EPS Shows BJP Who Is The Boss in Tamil Nadu

Rediff.com9 Sep 2025

'The EPS camp feels assertiveness will help the AIADMK keep the BJP's seat-share ambitions to the minimum,' observes N Sathiya Moorthy.

Parl panel advises caution in emergency approval of vaccine

Parl panel advises caution in emergency approval of vaccine

Rediff.com21 Dec 2020

In a report submitted Monday to Rajya Sabha chairman and Vice President M Venkaiah Naidu, the Parliamentary Standing Committee on Home Affairs also said there was a need for a comprehensive public health law to keep a tab on private hospitals and check black-marketing of medicines.

Serum's Covid vaccine, Covovax, recommended for approval

Serum's Covid vaccine, Covovax, recommended for approval

Rediff.com27 Dec 2021

The Pune-based firm had submitted interim safety and immunogenicity data of phase 2/3 bridging clinical trial conducted in the country as well as interim clinical trial data of safety and efficacy from phase3 clinical trials conducted in the UK and the US along with its application.

Bharat Biotech's Covaxin vaccine cleared by special panel

Bharat Biotech's Covaxin vaccine cleared by special panel

Rediff.com2 Jan 2021

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

Expert panel recommends granting emergency nod to Oxford vaccine

Expert panel recommends granting emergency nod to Oxford vaccine

Rediff.com2 Jan 2021

As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.

US court blocks Trump's major tariffs, says exceeds authority

US court blocks Trump's major tariffs, says exceeds authority

Rediff.com29 May 2025

A US federal court on Wednesday (local time) ruled against US President Donald Trump's large-scale imposition of sweeping tariffs, deeming that this move exceeds his legal authority and that it would affect a wide range of imported goods, as reported by CNN.

China authorises CoronaVac vaccine for 3-17 yr olds

China authorises CoronaVac vaccine for 3-17 yr olds

Rediff.com6 Jun 2021

The Wold Health Organisation has granted approval on June 1 to China's second COVID-19 vaccine, Sinovac, which was expected to strengthen China's vaccine diplomacy.

Govt denies pressuring Covaxin makers for early release of vaccine

Govt denies pressuring Covaxin makers for early release of vaccine

Rediff.com17 Nov 2022

The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.

Time To Tackle The Digital Fraud Surge

Time To Tackle The Digital Fraud Surge

Rediff.com14 Aug 2025

We propose an expert group be set up to form a national strategy on digital fraud. This group would bring together skills in financial regulation, security economics, cyber defence, and public communications, and an understanding of the Indian financial and security systems. It should lay the foundations of a coordinated approach by the Indian State in fighting digital fraud, suggest Ajay Shah and Nandkumar Saravade.

Johnson & Johnson's single-dose COVID vaccine gets approval in India

Johnson & Johnson's single-dose COVID vaccine gets approval in India

Rediff.com7 Aug 2021

"India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against COVID-19," tweeted the minister.

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Rediff.com26 Apr 2022

The approval by the Drugs Controller General of India comes following recommendations by the Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation.

Govt issues advisory for rational use of Remdesivir

Govt issues advisory for rational use of Remdesivir

Rediff.com7 Jun 2021

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.

Ceasefire, But Pakistan's Cyber War Continues

Ceasefire, But Pakistan's Cyber War Continues

Rediff.com26 May 2025

More than one million cybersecurity incidents were flagged within 10 days.

Cong leaders raise concern over emergency vaccine nod

Cong leaders raise concern over emergency vaccine nod

Rediff.com4 Jan 2021

Senior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for restricted use of Bharat Biotech's COVID-19 vaccine and asked the government to explain why mandatory protocols and verification of data has been dispensed with.

Enhance civil defence measures: MHA to states, UTs amid Pak attacks

Enhance civil defence measures: MHA to states, UTs amid Pak attacks

Rediff.com9 May 2025

In the letter issued, considering the last night attacks by Pakistani forces in Jammu and Jaisalmer regions, the provision also authorises the use of local authority funds for such emergency measures, giving them precedence over other financial obligations.

Covaxin recommended by expert panel for 2-18 years

Covaxin recommended by expert panel for 2-18 years

Rediff.com12 Oct 2021

The Subject Expert Committee on COVID-19 examined the data and deliberated on the EUA application on Monday.

Expert panel seeks more data on SII, Bharat Biotech vaccines

Expert panel seeks more data on SII, Bharat Biotech vaccines

Rediff.com10 Dec 2020

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.

4 more Covid vaccines in pipeline: Health ministry

4 more Covid vaccines in pipeline: Health ministry

Rediff.com12 Jan 2021

Addressing a press briefing, Union Health Secretary Rajesh Bhushan said Zydus Cadila, Sputnik V, Biological E and Gennova are other vaccines also in the pipeline which are in advanced clinical trials in India.

India likely to have Covid vaccine in new year: DCGI

India likely to have Covid vaccine in new year: DCGI

Rediff.com31 Dec 2020

The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.

Rana not in custody, says US Bureau of Prisons

Rana not in custody, says US Bureau of Prisons

Rediff.com10 Apr 2025

Tahawwur Rana, accused in the 2008 Mumbai terror attacks, has been extradited to India after the US Supreme Court denied his last-ditch effort to avoid being sent back. Rana, a close associate of David Coleman Headley, another key conspirator in the attacks, was expected to be extradited "shortly" after his legal appeals failed. This decision comes after a multi-agency team from India traveled to the US to complete all necessary paperwork and legalities with the US authorities. Rana's extradition marks a significant development in the pursuit of justice for the victims of the Mumbai attacks.

G20 leaders agree to strengthen WHO to fast-track EUA for Covid vax: Goyal

G20 leaders agree to strengthen WHO to fast-track EUA for Covid vax: Goyal

Rediff.com31 Oct 2021

Briefing the media in Rome, Goyal said the Leaders adopted the 'Rome Declaration' at the G20 Summit and the communique gives a very strong message under the health section with the countries agreeing that the COVID-19 immunisation is a global public good.

US allows use of plasma treatment for COVID patients

US allows use of plasma treatment for COVID patients

Rediff.com24 Aug 2020

The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.

3 COVID vaccines under active consideration: Health ministry

3 COVID vaccines under active consideration: Health ministry

Rediff.com8 Dec 2020

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.

A COVID-19 Vaccine Snapshot

A COVID-19 Vaccine Snapshot

Rediff.com28 Apr 2021

Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria.

WHO to decide next week on approval to Covaxin

WHO to decide next week on approval to Covaxin

Rediff.com5 Oct 2021

'WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin,' the global health body tweeted.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Covid vaccines for children likely by Sept: AIIMS chief

Covid vaccines for children likely by Sept: AIIMS chief

Rediff.com24 Jul 2021

The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.

When India Threatened Lahore To Stop Pakistan's Moves In J&K

When India Threatened Lahore To Stop Pakistan's Moves In J&K

Rediff.com28 May 2025

In what was perhaps the most critical meeting before full-scale war broke out, Shastri defined India's immediate war objectives to his defence minister, army, and air force chiefs: 'To defend against Pakistan's attempts to grab Kashmir by force and to make it abundantly clear that Pakistan would never be allowed to wrest Kashmir from India; To destroy the offensive power of Pakistan's armed forces...' A fascinating excerpt from Shiv Kunal Verma's must-read 1965: A Western Sunrise India's War With Pakistan.

Covishield accounts for 88% of Covid jabs in India

Covishield accounts for 88% of Covid jabs in India

Rediff.com1 Jan 2022

Serum Institute has the capacity to make 250 million doses of Covishield monthly.

Entire Prayagraj to become 'no vehicle zone' for Purnima snan

Entire Prayagraj to become 'no vehicle zone' for Purnima snan

Rediff.com11 Feb 2025

Elaborate arrangements including a special traffic plan have been chalked out for Maghi Purnima on Wednesday and health personnel have been put on alert for the occasion when the month-long 'kalpavas', an integral tradition of the Maha Kumbh, comes to an end.

Expect WHO nod to Covaxin in July-Sept: Bharat Biotech

Expect WHO nod to Covaxin in July-Sept: Bharat Biotech

Rediff.com25 May 2021

The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.

India to produce 850mn Sputnik doses annually: RDIF

India to produce 850mn Sputnik doses annually: RDIF

Rediff.com13 Apr 2021

As per RDIF, Sputnik V has a number of key advantages, including that there are no strong allergies caused by Sputnik V.

India gets 3rd vaccine as DCGI approves Sputnik V

India gets 3rd vaccine as DCGI approves Sputnik V

Rediff.com13 Apr 2021

According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.

'None of the existing vaccines can prevent emerging variants of Omicron'

'None of the existing vaccines can prevent emerging variants of Omicron'

Rediff.com25 Jan 2023

'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'

Only Covaxin available for 15-18-yr-olds, for now

Only Covaxin available for 15-18-yr-olds, for now

Rediff.com27 Dec 2021

Healthcare and frontline workers and citizens above 60 years of age with comorbidities would be administered the third dose of the same vaccine they had been given before.